Urology · Tallahassee, FL
NPI
1386607117
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2000 Centre Pointe Blvd
Tallahassee, FL, 32308
Phone (850) 309-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$331K
19,915 services
Medicare patients, 2024
867
Average age 76
Drug cost, 2024
$860K
5,833 prescriptions
Company payments, 2025
$1,031
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James E Renehan was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 3,000 times for 30 patients. In total James E Renehan billed 19,915 services in 88 codes, and Medicare paid $331K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,000 | 30 | $0.10 | $307 |
| 99214 Office E&M - Established | Office | 1,190 | 674 | $98.82 | $118K |
| 81003 Clinical Chemistry | Office | 1,008 | 633 | $2.20 | $2,214 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 691 | 463 | $12.72 | $8,793 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 457 | 84 | $51.76 | $24K |
| 36415 Venipuncture Blood Collection | Office | 390 | 263 | $6.88 | $2,684 |
| 51798 Ultrasound - Nonspecific | Office | 276 | 191 | $8.37 | $2,311 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 155 | 21 | $139.40 | $22K |
| 74018 Standard X-ray | Office | 141 | 113 | $22.37 | $3,154 |
| 99213 Office E&M - Established | Office | 130 | 115 | $69.08 | $8,980 |
| 81001 Clinical Chemistry | Office | 118 | 100 | $3.09 | $364 |
| 99204 Office E&M - New | Office | 99 | 99 | $125.96 | $12K |
| 52000 Cystourethroscopy | Facility | 70 | 62 | $59.78 | $4,185 |
| 96372 Injection Administration | Office | 60 | 43 | $10.25 | $615 |
| 96402 Chemotherapy Administration | Office | 57 | 27 | $27.74 | $1,581 |
By year: 2022 $265K for 13,532 services; 2023 $266K for 21,260 services; 2024 $331K for 19,915 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,008 | 633 | $2.20 | $2,214 |
| 36415 Venipuncture Blood Collection | 390 | 263 | $6.88 | $2,684 |
| 81001 Clinical Chemistry | 118 | 100 | $3.09 | $364 |
| 81002 Clinical Chemistry | 50 | 45 | $3.41 | $171 |
Medicare prescription drug claims, 2024
In 2024, the drug James E Renehan prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,346 prescriptions and refills. In total James E Renehan wrote 5,833 Medicare prescriptions that cost $860K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,346 | 3,747 | 435 | $29K |
| Myrbetriq Mirabegron | 748 | 1,382 | 201 | $602K |
| Finasteride Generic | 674 | 1,906 | 229 | $9,602 |
| Solifenacin Succinate Generic | 399 | 1,022 | 142 | $15K |
| Ciprofloxacin Hcl Generic | 324 | 324 | 187 | $1,293 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 236 | 649 | 72 | $6,517 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 228 | 228 | 112 | $2,092 |
| Levofloxacin Generic | 185 | 185 | 151 | $710 |
| Silodosin Generic | 165 | 401 | 55 | $15K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 165 | 406 | 47 | $3,891 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 159 | 390 | 52 | $14K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 150 | 257 | 48 | $5,229 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 111 | 119 | 85 | $382 |
| Gemtesa Vibegron | 107 | 229 | 38 | $105K |
| Testosterone Generic | 98 | 121 | 28 | $12K |
Brand drugs: - claims; generic drugs: 4,883 claims; opioid claims: 90.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James E Renehan $1,031 ($1,031 in general payments such as food, travel and fees) from 17 companies. The largest payer was Sumitomo Pharma America, Inc. with $190.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 12 | $190 |
| Olympus America Inc. | 4 | $189 |
| Boston Scientific Corporation BSX | 6 | $143 |
| Dendreon Pharmaceuticals LLC | 3 | $89.78 |
| Abbvie Inc. ABBV | 3 | $66.1 |
| Endo USA, Inc. | 3 | $58.68 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $45.92 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $41.85 |
| Verity Pharmaceuticals Inc. | 1 | $28.03 |
| Tolmar, Inc. | 1 | $25.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.